Optical Spectroscopy Study of the Interaction Between Quercetin and Human Serum Albumin

• Authors: T. Wybranowski , S. Kruszewski
• Languages of publication: EN

Abstracts

EN

Optical methods are very useful for the study on behavior of molecules in albumin-containing solutions. The interaction between quercetin (QUE) and human serum albumin (HSA) under physiological conditions was investigated by the methods of UV-Vis absorption and fluorescence spectroscopy. Fluorescence data show that enhancing of quercetin fluorescence in the presence of HSA is the result of formation of the HSA-QUE complex. On the basis of fluorescence data, the binding affinity constant of quercetin to HSA is determined. In this paper we have attempted to perform a kinetic study of the oxidation of quercetin in presence of human serum albumin by absorption spectroscopy. It has been shown that quercetin easily oxidizes at pH 7.4. The addition of HSA to quercetin solution induces changes in the absorption spectrum. In the human serum albumin solution, the time of quercetin oxidation is longer than in the case of quercetin diluted in phosphate buffered saline. Human albumin also contributes to stabilization of quercetin. These results suggest that HSA prevents degradation of quercetin in blood.

Keywords

EN

87.64.K-; 87.64.kv; 87.15.kp

Discipline

• 87.15.kp: Protein-ligand interactions
• 87.64.K-: Spectroscopy
• 87.64.kv: Fluorescence

• Publisher: Institute of Physics, Polish Academy of Sciences
• Journal: Acta Physica Polonica A
• Year: 2014
• Volume: 125
• Issue: 4A
• Pages: A-57-A-60

Dates

published

2014-04

Contributors

author

T. Wybranowski

• Medical Physics Division, Biophysics Department, Collegium Medicum of Nicolaus Copernicus University Jagiellońska 13, 85-067 Bydgoszcz, Poland

author

S. Kruszewski

• Medical Physics Division, Biophysics Department, Collegium Medicum of Nicolaus Copernicus University Jagiellońska 13, 85-067 Bydgoszcz, Poland

References

• [1] U. Kragh-Hansen, V.T.G. Chuang, M. Otagiri, Biol. Pharm. Bull. 25, 695 (2002), doi:10.1248/bpb.25.695
• [2] C. Bertucci, V. Andrisano, R. Gotti, J. Chromatogr. B 768, 147 (2002), doi:10.1016/S0378-4347(01)00494-7
• [3] G. Sudlow, D.J. Birkett, D.N. Wade, Mol. Pharmacol. 11, 824 (1975)
• [4] Y. Ni, S. Su, S. Kokot, Anal. Chim. Acta 580, 206 (2006), doi:10.1016/j.aca.2006.07.059
• [5] H. Mandula, J.M. Parepally, R. Feng, Q.R. Smith, J. Pharmacol. Exp. Ther. 317, 667 (2006), doi:10.1124/jpet.105.097402
• [6] U. Kragh-Hansen, F. Hellec, B. de Foresta, M. le Maire, J.V. Møller, Biophys. J 80, 2898 (2001), doi:10.1016/S0006-3495(01)76255-8
• [7] B. Sengupta, P.K. Sengupta, Biochem. Biophys. Res. Commun. 299, 400 (2002), doi:10.1016/S0006-291X(02)02667-0
• [8] C.D. Kanakis, P.A. Tarantilis, M. Polissiou, S. Diamantoglou, H.A. Tajmir-Riahi , J. Mol. Struct. 798, 69 (2006), doi:10.1016/j.molstruc.2006.03.051
• [9] S.B. Bukhari, S. Memon, M. Mahroof-Tahir, M.I. Bhanger, Spectrochim. Acta A Mol. Biomol. Spectrosc. 71, 1901 (2009), doi:10.1016/j.saa.2008.07.030
• [10] B. Mishra, A. Barik, I.K. Priyadarsini, H. Mohan, J. Chem. Sci. 117, 641 (2005), doi:10.1007/BF02708293
• [11] O. Dangles, C. Dufour , S. Bret , J. Chem. Soc., Perkin Trans. 2, 737 (1999), doi:10.1039/a810017i
• [12] O. Dangles, G. Fargeix, C. Dufour, J. Chem. Soc., Perkin Trans. 2, 1387 (1999), doi:10.1039/a901460h
• [13] B. Ziomkowska, S. Kruszewski, M. Cyrankiewicz, Comb. Chem. High Thr. Screen 10, 459 (2007), doi:10.2174/138620707781996394

Identifiers

DOI

10.12693/APhysPolA.125.A-57